BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20674881)

  • 1. Report of the 2nd "French Clinical Vaccinology Meeting Jean-Gerard Guillet": immunization and respiratory diseases.
    Loulergue P; Burgel PR; Carrat F; Fritzell B; Guthmann JP; Locht C; Power UF; Varon E; Dusser D; Launay O
    Vaccine; 2010 Sep; 28(40):6551-5. PubMed ID: 20674881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to the First Clinical Vaccinology Meeting "Jean-Gérard Guillet".
    Loulergue P; Launay O
    J Clin Virol; 2009 Nov; 46(3):201. PubMed ID: 19473875
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccines for all: Institut Pasteur vaccinology course, 2010.
    Altindiş E
    Expert Rev Vaccines; 2010 Sep; 9(9):1023-6. PubMed ID: 20822345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From fundamental immunology to development of vaccinology].
    Choppin J
    Med Sci (Paris); 2008 Jan; 24(1):56-60. PubMed ID: 18198111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues in pneumococcal disease and pneumococcal conjugate vaccines: highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9-13, 2009.
    Adam D
    Vaccine; 2009 Nov; 27(50):7133-7. PubMed ID: 19883868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines.
    Durbin AP; Karron RA
    Clin Infect Dis; 2003 Dec; 37(12):1668-77. PubMed ID: 14689350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza and pneumococcal immunization rates among a high-risk population.
    Chan-Tack KM
    South Med J; 2001 Mar; 94(3):323-4. PubMed ID: 11284519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunization and immuno-modulation for prevention of respiratory tract infections].
    Mazza-Stalder J; Siegrist CA; Janssens JP
    Rev Med Suisse; 2005 Nov; 1(41):2645-6, 2649-51. PubMed ID: 16355878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and bovine respiratory syncytial virus vaccine research and development.
    Meyer G; Deplanche M; Schelcher F
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):191-225. PubMed ID: 17720245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of live influenza virus vaccine in patients with chronic bronchitis. Report to Medical Research Council's Committee on Influenza and Other Respiratory Virus Vaccines. Advisory Group on pulmonary function tests in relation to live influenza virus vaccines.
    Br J Dis Chest; 1980 Apr; 74(2):121-7. PubMed ID: 7426351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection.
    Ampofo K; Bender J; Sheng X; Korgenski K; Daly J; Pavia AT; Byington CL
    Pediatrics; 2008 Aug; 122(2):229-37. PubMed ID: 18676537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenicity and reactogenicity of DTPa-IPV-HBV/Hib and DTPa-IPV/Hib vaccines coadministered with 7-valent pneumococcal conjugate vaccine as primary vaccination and booster in healthy infants, according to the French vaccination calendar].
    Reinert P; Dejos V; Clyti N; Abitbol V
    Arch Pediatr; 2008 Mar; 15(3):263-70. PubMed ID: 18272353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs, new vaccines, new diseases. An interview with Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID).
    Fuller J
    Glob Issues; 1996 Nov; 1(17):10-3. PubMed ID: 12349252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress with human H5N1 vaccines: a perspective from industry.
    Palache B; Krause R
    Expert Rev Vaccines; 2009 Apr; 8(4):391-400. PubMed ID: 19348556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on research and development pipeline: tuberculosis vaccines.
    Beresford B; Sadoff JC
    Clin Infect Dis; 2010 May; 50 Suppl 3():S178-83. PubMed ID: 20397946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunization guidelines regarding patients with a chronic disease].
    Aubert C; Vaudaux B; Bart PA;
    Rev Med Suisse; 2010 Apr; 6(245):798-803. PubMed ID: 20469661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for persons at high risk, 2007.
    Zimmerman RK; Middleton DB
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S38-46, C4-5. PubMed ID: 17270109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second Geneva Consensus: Recommendations for novel live TB vaccines.
    Walker KB; Brennan MJ; Ho MM; Eskola J; Thiry G; Sadoff J; Dobbelaer R; Grode L; Liu MA; Fruth U; Lambert PH
    Vaccine; 2010 Mar; 28(11):2259-70. PubMed ID: 20074686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower respiratory tract infections: prevention using vaccines.
    Whitney CG; Harper SA
    Infect Dis Clin North Am; 2004 Dec; 18(4):899-917. PubMed ID: 15555831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on universal childhood immunizations.
    Hamlin J; Senthilnathan S; Bernstein HH
    Curr Opin Pediatr; 2008 Aug; 20(4):483-9. PubMed ID: 18622208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.